Profit Margin (Quarterly) Chart

View Profit Margin (Quarterly) for LNTH.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Profit Margin (Quarterly) Chart
Start Trial

Historical Profit Margin (Quarterly) Data

View and export this data back to 2011. Start Trial.
Date Value
June 30, 2026 19.33%
March 31, 2026 31.38%
December 31, 2025 13.30%
September 30, 2025 7.23%
June 30, 2025 20.83%
March 31, 2025 19.57%
December 31, 2024 -3.01%
September 30, 2024 34.61%
June 30, 2024 15.75%
March 31, 2024 35.43%
December 31, 2023 29.20%
September 30, 2023 41.24%
June 30, 2023 29.26%
March 31, 2023 -0.93%
December 31, 2022 -45.29%
September 30, 2022 25.59%
June 30, 2022 19.25%
March 31, 2022 20.57%
December 31, 2021 -31.04%
September 30, 2021 -13.14%
June 30, 2021 -26.38%
March 31, 2021 9.74%
December 31, 2020 -3.62%
September 30, 2020 -7.21%
June 30, 2020 -10.62%
Date Value
March 31, 2020 3.68%
December 31, 2019 11.70%
September 30, 2019 5.66%
June 30, 2019 7.48%
March 31, 2019 11.50%
December 31, 2018 15.41%
September 30, 2018 10.43%
June 30, 2018 11.39%
March 31, 2018 9.94%
December 31, 2017
September 30, 2017 10.67%
June 30, 2017 15.30%
March 31, 2017 5.09%
December 31, 2016 6.55%
September 30, 2016 5.78%
June 30, 2016 9.43%
March 31, 2016 13.50%
December 31, 2015 5.50%
September 30, 2015 7.27%
June 30, 2015 -33.31%
March 31, 2015 0.50%
December 31, 2014 -2.72%
September 30, 2014 -1.15%
June 30, 2014 -2.16%
March 31, 2014 -1.75%

Profit Margin Definition

Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.

Read full definition.

Profit Margin (Quarterly) Range, Past 5 Years

View Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Profit Margin (Quarterly) Benchmarks

View Profit Margin (Quarterly) Benchmarks
Start Trial
Integer Holdings Corp. 5.13%
Globus Medical, Inc. 19.20%
iRhythm Holdings, Inc. -0.17%
Abbott Laboratories 7.37%
Align Technology, Inc. 10.25%